H. Lundbeck A — Director's Dealing 2011

Aug 22, 2011

Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities

Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities

H. Lundbeck A/S hereby reports transactions made by executives and persons and legal entities closely associated to them with shares in H. Lundbeck A/S and linked securities, cf. section 28a of the Danish Securities Trading Act.

The list is based on reports received by H. Lundbeck A/S from the company's executives today or yesterday.

Name:	Sven Håkan Björklund
Job position of the executive:	Board member
ID code (ISIN code):	DK 0010287234
Description of the security:	Share
Nature of the transaction:	Purchase of shares
Date of trading:	22 August 2011
Market on which the trading was effected:	Nasdaq OMX Copenhagen
Number of traded securities:	1,662 shares
Market price of securities traded:	DKK 198,941

Persons or entities under an obligation to report are defined as members of the Executive Management and the Supervisory Board of H. Lundbeck A/S and persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

• spouse or cohabitant

• children below the age of 18

• legal entities in which the insider has a controlling influence                                      

The content of this release will have no influence on the Lundbeck Group's financial expectations for 2011.                     

Lundbeck contacts

Investors:	Media:
Palle Holm Olesen	Mads Kronborg
Chief Specialist, Investor Relations	Media Relations Manager
palo@lundbeck.com	mavk@lundbeck.com
+45 36 43 24 26	+45 36 43 28 51
Magnus Thorstholm Jensen	Simon Mehl Augustesen
Investor Relations Officer	International Media Specialist
matj@lundbeck.com	smeh@lundbeck.com
+45 36 43 38 16	+45 36 43 49 80
Jacob Tolstrup
Vice President
jtl@lundbeck.com
+1 847 282 5713

**

About Lundbeck

**H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international pharmaceutical company highly committed to improving the quality of life for people suffering from central nervous system (CNS) disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company's products are targeted at disorders such as depression and anxiety, schizophrenia, insomnia, epilepsy and Huntington's, Alzheimer's and Parkinson's diseases.

Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today Lundbeck employs approximately 5,900 people worldwide. Lundbeck is one of the world's leading pharmaceutical companies working with CNS disorders. In 2010, the company's revenue was DKK 14.8 billion (approximately EUR 2.0 billion or USD 2.6 billion). For more information, please visit www.lundbeck.com.

HUG#1540141

Attachments:

• Release no 446

  ---

  This content was distributed through

  

  Create value through communication

  Visit us here.